Treatment of Relapsed Adult Acute Lymphoblastic Leukemia with Fludarabine and Cytosine Arabinoside Followed by Granulocyte Colony-Stimulating Factor (FLAG-GCSF)

References

• Hoelzer D., Thiel E., Loffler H., Buchner T., Ganser A., Heil G., Koch P., Freund M., Diedrich H., Ruhl H., Mashmeyer G., Lipp T., Nowrousian M. R., Burkerl M., Gerecke D., Pralle H., Muller U., Lunscken Ch., Fulle H., Ho A. D., Kuchler R., Bush F. W., Shneider W., Gorg Ch., Emmerich B., Brauman D., Vaupel H. A., Von Paleske A., Bartels H., Neiss Amesserer D. Prognostic factors in multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 1988; 71: 123–33
   PubMed Web of Science ®Google Scholar
• Linker C. A., Levitt L. J., O'Donnell M. Improved results of treatment of adult acute lymphoblastic leukemia. Blood 1987; 69: 1242–8
   PubMed Web of Science ®Google Scholar
• Suki S., Kantarjian H., Gandhi V., Estey E., O'Brien S., Bera M., Rios M. B., Plunkett W., Keating M. Fludarabine and Cytosine Arabinoside in the treatment of refractory or relapsed acute Lymphocitic leukemia. Cancer 1993; 72: 2155–2160
   PubMed Web of Science ®Google Scholar
• Hoelzer D., Gale R. P. Acute lymphoblastic leukemia in adults: recent progress, future directions. Semin, Hematol. 1987; 24: 27–39
   PubMed Web of Science ®Google Scholar
• Freund M., Diedrich H., Ganser A. Treatment of relapsed or refractory adult acute lymphoblastic leukemia. Cancer 1992; 69: 709–716
   PubMed Web of Science ®Google Scholar
• Freund M., De Boden, Diedrich H. Treatment of relapsed acute lymphocytic leukemia in adults. Haematology and Blood, J. Buchner, G. Schellong, W. Hiddeman, J. Ritter. Springer‐Verlag, Munster, FRG 1990; 432–436
   Google Scholar
• Jacobs A. D., Gale R. P. Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. New Eng. J. Med. 1984; 311: 1219–1231
   PubMed Web of Science ®Google Scholar
• Mathé G., Misset J. L., De Vassal F. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma and Hodgkins disease: absence of cross‐resistance with vincristine. Cane. Treat. Reports. 1978; 62: 805–809
   PubMedGoogle Scholar
• Kantarjian H. M., Walters R. L., Keating M. J., Estey E. H., O'Brien S., Schachner J., McCredie K. B., Freireiches J. Miloxantrone and high dose Cytosine arabinoside for the treatment of acute lymphocytic leukemia. Cancer 1990; 65: 5–8
   PubMed Web of Science ®Google Scholar
• Arlin Z. A., Felman E., Sandford K., Ahmed T., Mittelman A., Savona S., Ascensao J., Baskind P., Sullivan P., Fuhr H. G., Mertelsmann R. Amsacrine with high dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults. Blood 1988; 72: 433–435
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Estey E. H., O'Brien S., Anaissie E., Beran M., Rios M. B., Keating M. J., Gutterman J. Intensive chemotherapy with mitoxantrone and high‐dose cytosine arabinoside followed by granulocyte‐macrophage stimulating factor in the treatment of patients with acute myphocytic leukemia. Blood 1992; 79: 876–881
   PubMed Web of Science ®Google Scholar
• Gandhy V., Kemena A., Keating M. J. Fludarabine potentiates arabinosyl‐cytosine metabolism in lymphocites of patients with chronic lymphocytic leukemia. Cancer. Res. 1992; 52: 897–903
   PubMed Web of Science ®Google Scholar
• Antman K. S., Griffin J. D., Elias A., Socinsky M. A., Ryan L., Cannistra S. A., Oette D., Whitley M., Frei E., III, Schnipper L. E. Effect of recombinant human granulo‐cyte‐macrophage colony stimulating factor on chemotherapy‐induced myelosuppression. N. Engl. J. Med. 1988; 319: 593–595
   PubMed Web of Science ®Google Scholar
• Mortsyn G., Campbell L., Souza L. M., Alton N. K., Keech J., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyle colony stimulating factor on neutropenia induced by cytoloxic chemotherapy. Lancet 1988; 1: 667–669
   PubMed Web of Science ®Google Scholar
• Nemunaitis J., Singer J. W., Buckner C. D., Hill R., Storb R., Thomas E. D., Applebaum F. R. Use of recombinant human granulocyte‐macrophage colony‐stimulating factor in autologus marrow transplantation for mymphoid malignancies. Blood 1988; 72: 834–836
   PubMed Web of Science ®Google Scholar
• Gianni A. M., Bregni M., Siena S., Orazi A., Stern A. C., Gandola L., Bonadonna G. Recombinant human granuloeyte‐macrophage colony‐stimulating factor reduces hematologic toxicity and widens clinical applicability of high dose cyclophosphamide treatment in breast cancer and non‐Hodgkins. Lymphoma. J. Clin. Oncol. 1990; 8: 768–778
   PubMed Web of Science ®Google Scholar
• Ohno R., Tomonaga M., Kobayashi T. Effect of granulocyte colony—stimulating factor after intensive induction chemotherapy in relapsed or refractory acute leukemia. N. Engl. J. Med. 1990; 323: 871–877
   PubMed Web of Science ®Google Scholar
• Scherre R., Geissler K., Kyrle P. A. Granulocyte colony stimulating factor (G‐CSF) as an adjuction to induction chemotherapy of adult acute lymphoblastic leukemia (ALL). Ann. Hematol. 1993; 66: 283–289
   PubMed Web of Science ®Google Scholar
• Warrel R., Berman E. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. J. Clin. Oncol. 1986; 4: 74–79
   PubMed Web of Science ®Google Scholar
• Chun H. G., Leyland‐Jones B. R., Caryk S. M., Hoth D. F. Central nervous system toxicity of fludarabine phosphate. Cancer Treat. Rep. 1986; 70: 1225–1228
   PubMedGoogle Scholar
• Ibayashi Y., Ohyama H., Hashimoto Y., Sakatani K., Morimoto S., Takahashi H., Shibata K., Kashiwabara S., Tanabe S., Hashi K. A case report of interstitial pneumonia caused by granulocyte colony‐stimulating factor. No Shinkei Geka. 1994; 22: 169–174
   PubMedGoogle Scholar
• Kane G. C., McMichhael A. J., Patrick H., Erslev J. Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate. Respiratory Medicine 1992; 86: 261–263
   PubMed Web of Science ®Google Scholar
• Yang L. Y., Trujillo J. M., Keating M. J. Effect of fludarabine on the tumoricidal synergy produced by the combination of arabinosylcytosine and cisplatin in human LoVo colon carcinoma cells. Proc. Am. Assoc. Cancer Res. 1992; 33: 443
   Google Scholar
• Robertson L. E., Kantarjian H., O'Brien S. Cisplatin. fludarabine and ara‐C: A regimen for advanced refractory chronic lymphocytic leukemia. Proc. Am. Assoc. Cancer Res. 1993; 34: 347
   Google Scholar
• Keating M. J., O'Brien S., Robertson L. E., Kantarjian H., Dimopoulos M., McLaughlin P., Cabanillas F., Gregoire V., Yang L. Y., Gandhi V., Estey E., Plunkett W. New initiatives with fludarabine monophosphate in hematologic malignancies. Semin. Oncol. 1993; 5: 13–20
   Google Scholar